EUVIMEDEUVIMED entdecken
Multizentrische Studie

Transcatheter tricuspid valve‐in‐valve implantation for degenerated surgical bioprosthesis

Jinmiao Chen iD, Ye Yang, Wenyu Song, Deguang Feng, Yang Yan, Chunsheng Wang, Lai Wei

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30554 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Jinmiao Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Bioprosthesis, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Sailing Program, Clinical Research Fund of Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Isolated redo surgery for degenerated tricuspid bioprosthesis is of very high risk. We aimed to evaluate the safety and efficacy of transcatheter valve‐in‐valve (TVIV) implantation using a novel balloon expandable Renato valve.

Methods

A prospective multicenter study was conducted to enroll patients with degenerated tricuspid bioprostheses. A total of 12 patients underwent TVIV implantation using the Renato valve system via transfemoral, transjugular, or transatrial approaches at three institutions from May 2021 to October 2021. All‐cause mortality and hemodynamic performance were evaluated up to 6 months after procedure.

Results

The median age was 68.2 years, and 75.0% were female. Six patients had a history of rheumatic left‐sided valve surgery and late tricuspid valve replacement. The median preoperative Society of Thoracic Surgeons score was 9.9%. The procedures were successful in all cases. Tricuspid regurgitation and paravalvular leak were none or mild in all patients. The median transvalvular gradient decreased from 7.8 mmHg preoperatively to 4.5 mmHg at 6 months after TVIV, respectively. No death occurred and all patients recovered to New York Heart Association functional class I or II during a 6‐month follow‐up.

Conclusions

TVIV implantation with the Renato valve was a safe and effective treatment for degenerated bioprostheses in high‐risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioprosthesisHeart Valve Prosthesis ImplantationHeart Valve ProsthesisHumansFemaleAgedMaleTricuspid ValveTreatment OutcomeProspective StudiesProsthesis Failure

Stichwörter der Autor:innen

Renato valvedegenerated surgical bioprosthesisefficacysafetytranscatheter tricuspid valve-in-valve

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Cardiovascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China.

ORCID-Profile: Jinmiao Chen

Förderung

  • National Natural Science Foundation of China
  • Shanghai Sailing Program
  • Clinical Research Fund of Shanghai Municipal Health Commission
  • China Postdoctoral Science Foundation
  • Youth Research Fund of Zhongshan Hospital, Fudan University

Zitieren

APA

Chen, J., Yang, Y., Song, W., Feng, D., Yan, Y., Wang, C., & Wei, L. (2023). Transcatheter tricuspid valve‐in‐valve implantation for degenerated surgical bioprosthesis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30554

Vancouver

Chen J, Yang Y, Song W, Feng D, Yan Y, Wang C, et al. Transcatheter tricuspid valve‐in‐valve implantation for degenerated surgical bioprosthesis. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30554

BibTeX
@article{Chen2023,
  author = {Chen, Jinmiao and Yang, Ye and Song, Wenyu and Feng, Deguang and Yan, Yang and Wang, Chunsheng and Wei, Lai},
  title = {Transcatheter tricuspid valve‐in‐valve implantation for degenerated surgical bioprosthesis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30554}
}
Kostenlos starten →